Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

OACCOaktree Acquisition Corp. III Life Sciences

Nasdaq · CIK 0002029769
Filer categoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Entity typeoperating
SIC6770 Blank Checks
FY end1231
XBRL facts55

Identity from submissions API

NameOaktree Acquisition Corp. III Life Sciences
CIK0002029769
TickersOACC, OACCU, OACCW
ExchangesNasdaq, Nasdaq, Nasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
SIC6770 Blank Checks
EIN000000000
LEI—
Fiscal year end1231
State of incorporationE9 Cayman Islands
Phone213-830-6300
Website—
Investor website—
Owner org05 Real Estate & Construction
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • None listed.
Business address
333 SOUTH GRAND AVENUE, 28TH FLOOR
LOS ANGELES
CA
90071
CA
Mailing address
333 SOUTH GRAND AVENUE, 28TH FLOOR
LOS ANGELES
CA
90071
CA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

69 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001950677-26-000036 005-94673 261560228 34 8426
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001688382-26-000047 005-94673 261559650 34 10929
2026-11-13 10-Q 10-Q 0001193125-26-460799 001-42383 261553246 34 4285523 1 1
2026-10-26 8-K 8-K 3.02,5.03,5.07,9.01 0001193125-26-430980 001-42383 261483385 34 224872 1 1
2026-10-23 4 4 0001193125-26-430503 15684
2026-10-16 DEFA14A DEFA14A 0001193125-26-423331 001-42383 261464275 34 23533
2026-10-16 8-K 8-K 7.01 0001193125-26-423329 001-42383 261464270 34 195435 1 1
2026-10-15 DEFA14A DEFA14A 0001193125-26-422266 001-42383 261461327 34 23133
2026-10-15 8-K 8-K 7.01 0001193125-26-422263 001-42383 261461324 34 194780 1 1
2026-10-02 DEF 14A DEF 14A 0001193125-26-412601 001-42383 261437883 34 406784
2026-09-21 PRE 14A PRE 14A 0001193125-26-396720 001-42383 261394302 34 396533
2026-08-14 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001950677-26-000024 005-94673 261283622 34 8355
2026-08-13 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000312069-26-000209 005-94673 261275421 34 6171
2026-08-12 10-Q 10-Q 0001193125-26-346973 001-42383 261268008 34 4039673 1 1
2026-05-15 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001688382-26-000017 005-94673 26985688 34 77905
2026-05-13 10-Q 10-Q 0001193125-26-221814 001-42383 26974175 34 3731715 1 1
2026-05-11 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000886982-26-000205 005-94673 26962584 34 18219
2026-03-26 10-K 10-K 0001193125-26-126536 001-42383 26799143 34 5058116 1 1
2026-02-11 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000312069-26-000052 005-94673 26620745 34 6151
2025-11-13 10-Q 10-Q 0001193125-25-280296 001-42383 251479175 34 3974165 1 1
2025-10-29 3 3 0001193125-25-256847 13923
2025-10-29 8-K 8-K 5.02 0001193125-25-256604 001-42383 251430797 34 191299 1 1
2025-10-22 3 3 0001193125-25-246855 13793
2025-10-17 8-K 8-K 5.02 0001193125-25-242643 001-42383 251401587 34 192300 1 1
2025-08-12 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000769993-25-000426 005-94673 251205432 34 17193
2025-08-12 10-Q 10-Q 0001193125-25-178570 001-42383 251204616 34 3593208 1 1
2025-07-15 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-068094 005-94673 251124902 34 15425
2025-06-16 3 3 0000950170-25-086786 15098
2025-06-06 8-K 8-K 5.02 0001193125-25-137105 001-42383 251031158 34 191756 1 1
2025-05-14 10-Q 10-Q 0001193125-25-119885 001-42383 25946293 34 3276861 1 1
2025-05-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000950170-25-071410 005-94673 25945695 34 8359
2025-05-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001085146-25-003132 005-94673 25944012 34 10221
2025-05-13 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000312069-25-000398 005-94673 25941299 34 6050
2025-05-09 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000769993-25-000246 005-94673 25929256 34 16547
2025-03-27 10-K 10-K 0001193125-25-065546 001-42383 25779865 34 1401263
2025-02-14 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000950170-25-021134 005-94673 25628029 34 8275
2025-02-12 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000950170-25-019260 005-94673 25616862 34 36108
2025-01-07 8-K 8-K 5.02 0001193125-25-002863 001-42383 25515226 34 20284
2024-12-11 8-K 8-K 8.01,9.01 0001193125-24-274894 001-42383 241540246 34 31089
2024-11-07 SC 13G AQR CAPITAL MANAGEMENT LLC 0001085146-24-005427 005-94673 241435231 34 45359
2024-11-05 8-K 8-K 3.02,8.01,9.01 0001193125-24-251274 001-42383 241427952 34 100707
2024-10-31 4 4 0000950170-24-119552 61899
2024-10-31 8-K 8-K 8.01,9.01 0001193125-24-248669 001-42383 241415291 34 145209
2024-10-30 SC 13G OACC_SC13G.htm 0001273087-24-000110 005-94673 241410998 34 82127
2024-10-25 8-K 8-K 1.01,3.02,5.03,8.01,9.01 0001193125-24-244185 001-42383 241397574 34 1234763
2024-10-24 424B4 424B4 0001193125-24-242948 333-282508 241393324 33 1885097
2024-10-24 CERT 8A_Cert_OACC.pdf 0001354457-24-000827 001-42383 241390806 34 761575
2024-10-23 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2024-10-23 16:30:00 9999999995-24-003251 333-282508 241390447 33 1789
2024-10-23 3 3 0000950170-24-116810 63092
2024-10-23 3 3 0000950170-24-116805 18977
2024-10-23 3 3 0000950170-24-116802 18471
2024-10-23 3 3 0000950170-24-116799 18312
2024-10-23 3 3 0000950170-24-116798 18511
2024-10-23 3 3 0000950170-24-116797 18797
2024-10-23 3 3 0000950170-24-116796 18416
2024-10-23 3 3 0000950170-24-116790 18367
2024-10-23 8-A12B 8-A12B 0001193125-24-241503 001-42383 241387951 34 16724
2024-10-21 CORRESP filename1.htm 0001193125-24-240542 8681
2024-10-21 CORRESP filename1.htm 0001193125-24-240541 13968
2024-10-18 CORRESP filename1.htm 0001193125-24-239703 12376
2024-10-18 S-1/A S-1/A 0001193125-24-239699 333-282508 241381353 33 1955442
2024-10-18 UPLOAD filename1.pdf 0000000000-24-011712 377-07367 44465
2024-10-04 CORRESP filename1.htm 0001193125-24-233107 17912
2024-10-04 S-1 S-1 0001193125-24-233080 333-282508 241355201 33 3569739
2024-10-01 UPLOAD filename1.pdf 0000000000-24-011118 377-07367 47438
2024-09-13 DRSLTR filename1.htm 0000950123-24-009225 33306
2024-09-13 DRS/A filename1.htm 0000950123-24-009224 377-07367 241298520 33 3405637
2024-09-05 UPLOAD filename1.pdf 0000000000-24-010081 377-07367 56058
2024-08-07 DRS filename1.htm 0000950123-24-007251 377-07367 241180935 33 1919612

Latest XBRL company facts

One latest value per concept from companyfacts (55 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityPublicFloat Entity Public Float USD 200.63M 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126536
us-gaap AccountsPayableAndAccruedLiabilitiesCurrent Accounts Payable and Accrued Liabilities, Current USD 2.83M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460799
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 0 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460799
us-gaap AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD 11.59M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460799
us-gaap AdjustmentsToAdditionalPaidInCapitalWarrantIssued Adjustments to Additional Paid in Capital, Warrant Issued USD 215,029 2024-06-28 2024-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126536
us-gaap Assets Assets USD 208.21M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460799
us-gaap AssetsCurrent Assets, Current USD 1.25M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460799
us-gaap AssetsHeldInTrustNoncurrent Assets Held-in-trust, Noncurrent USD 206.96M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460799
us-gaap Cash Cash USD 1.23M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460799
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 1.23M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460799
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 1.23M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460799
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect USD -209,362 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460799
us-gaap CashEquivalentsAtCarryingValue Cash Equivalents, at Carrying Value USD 0 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460799
us-gaap CashFDICInsuredAmount Cash, FDIC Insured Amount USD 250,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460799
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights USD/shares 11.5 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460799
us-gaap ClassOfWarrantOrRightOutstanding Class of Warrant or Right, Outstanding shares 3.96M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460799
us-gaap DeferredOfferingCosts Deferred Offering Costs USD 6.72M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460799
us-gaap ExpenseRelatedToDistributionOrServicingAndUnderwritingFees Expense Related to Distribution or Servicing and Underwriting Fees USD 3.84M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460799
us-gaap IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions Income (Loss) from Equity Method Investments, Net of Dividends or Distributions USD 4.25M 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-12 0001193125-25-178570
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD -89,984 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-12 0001193125-25-178570
us-gaap IncreaseDecreaseInDueToRelatedParties Increase (Decrease) in Due to Related Parties USD 225,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460799
us-gaap IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities Increase (Decrease) in Other Accounts Payable and Accrued Liabilities USD 2.32M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460799
us-gaap IncreaseDecreaseInPrepaidExpensesOther Increase (Decrease) in Prepaid Expenses, Other USD -92,025 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460799
us-gaap IncreaseDecreaseInPrepaidInsurance Increase (Decrease) in Prepaid Insurance USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460799
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 5.65M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460799
us-gaap Liabilities Liabilities USD 10.87M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460799
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 208.21M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460799
us-gaap LiabilitiesCurrent Liabilities, Current USD 3.85M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460799
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126536
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD 250,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460799
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -459,362 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460799
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD 2.55M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460799
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 5.65M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460799
us-gaap NotesPayableCurrent Notes Payable, Current USD 11,824 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460799
us-gaap NumberOfOperatingSegments Number of Operating Segments segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460799
us-gaap NumberOfReportableSegments Number of Reportable Segments segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460799
us-gaap OperatingCostsAndExpenses Operating Costs and Expenses USD 3.10M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460799
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -3.10M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460799
us-gaap PaymentsToAcquireOtherInvestments Payments to Acquire Other Investments USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126536
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460799
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 1.00M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460799
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460799
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460799
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460799
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 21,250 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460799
us-gaap PrepaidExpenseNoncurrent Prepaid Expense, Noncurrent USD 0 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126536
us-gaap ProceedsFromIssuanceOfPrivatePlacement Proceeds from Issuance of Private Placement USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126536
us-gaap RepaymentsOfRelatedPartyDebt Repayments of Related Party Debt USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126536
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -9.62M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460799
us-gaap SaleOfStockNumberOfSharesIssuedInTransaction Sale of Stock, Number of Shares Issued in Transaction shares 550,000 2024-06-28 2024-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126536
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD -9.62M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460799
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 25,000 2024-06-28 2024-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126536
us-gaap StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures USD 0 2024-06-28 2024-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126536
us-gaap TemporaryEquityAccretionToRedemptionValue Temporary Equity, Accretion to Redemption Value USD 1.68M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460799
us-gaap TemporaryEquityCarryingAmountAttributableToParent Temporary Equity, Carrying Amount, Attributable to Parent USD 206.96M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-460799

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →